Prophylactic use of N-methyl-D-aspartate (NMDA) antagonists
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jun 13, 2002
app pub date -
Oct 2, 2001
filing date -
Oct 2, 2000
priority date (Note) -
Published
status (Latency Note)
Importance
|
US Family Size
|
Non-US Coverage
|
Abstract
This invention provides a method of inhibiting in a mammal neurological damage resulting from impairment of glucose and/or oxygen supply to the brain, which method comprises administering to the mammal prior to the impairment of glucose and/or oxygen supply to the brain an amount of an NR2B subunit selective NMDA antagonist, which amount is effective in inhibiting neurological damage. This invention also provides a method of preventing primary hyperalgesia, secondary hyperalgesia, primary allodynia, secondary allodynia, or other pain caused by central sensitization, in a mammal, which method comprises administering to the mammal, prior to affliction with said pain, an amount of an NR2B subunit selective NMDA antagonist, which amount is effective in preventing said pain.
First Claim
Other Claims data not available
Family
| Country | kind | publication No. | Filing Date |
|---|---|---|---|
| IL | A0 | IL145685 | Sep 26, 2001 |
| EP | A1 | EP1674087 | Sep 28, 2001 |
| EP | A2 | EP1199067 | Sep 28, 2001 |
| AU | B2 | AU779152 | Sep 28, 2001 |
| CA | A1 | CA2357925 | Sep 28, 2001 |
| KR | A | KR20020027212 | Sep 29, 2001 |
| NZ | A | NZ514552 | Oct 01, 2001 |
| HU | A2 | HUP0104019 | Oct 01, 2001 |
| JP | A | JP2002322092 | Oct 02, 2001 |
International Classification(s)
- 2001 Application Filing Year
- A61K Class
- 10449 Applications Filed
- 3517 Patents Issued To-Date
- 33.66 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 4 Citation Count
- A61K Class
- 9.90 % this patent is cited more than
- 23 Age